% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Wilcox:282340,
author = {N. Wilcox and M. Dumont and A. González-Neira and S.
Carvalho and C. Joly Beauparlant and M. Crotti and C.
Luccarini and P. Soucy and S. Dubois and R. Nuñez-Torres
and G. Pita and E. J. Gardner and J. Dennis and M. R. Alonso
and N. Álvarez and C. Baynes and A. C. Collin-Deschesnes
and S. Desjardins and H. Becher and S. Behrens$^*$ and M. K.
Bolla and J. E. Castelao and J. Chang-Claude$^*$ and S.
Cornelissen and T. Dörk and C. Engel and M. Gago-Dominguez
and P. Guénel and A. Hadjisavvas and E. Hahnen and M.
Hartman and B. Herráez and A. Y. Jung$^*$ and R. Keeman and
M. Kiechle and J. Li and M. A. Loizidou and M. Lush and K.
Michailidou and M. I. Panayiotidis and X. Sim and S. H. Teo
and J. P. Tyrer and L. E. van der Kolk and C. Wahlström and
Q. Wang and J. R. B. Perry and J. Benitez and M. K. Schmidt
and R. K. Schmutzler and P. D. P. Pharoah and A. Droit and
A. M. Dunning and A. Kvist and P. Devilee and D. F. Easton
and J. Simard},
collaboration = {S. Investigators},
othercontributors = {B. K. Tan and V. K. M. Tan and S.-M. Tan and G. H. Lim and
E. Y. Tan and P. J. Ho and A. J. Khng},
title = {{E}xome sequencing identifies breast cancer susceptibility
genes and defines the contribution of coding variants to
breast cancer risk.},
journal = {Nature genetics},
volume = {55},
number = {9},
issn = {1061-4036},
address = {London},
publisher = {Macmillan Publishers Limited, part of Springer Nature},
reportid = {DKFZ-2023-01724},
pages = {1435-1439},
year = {2023},
note = {2023 Sep;55(9):1435-1439},
abstract = {Linkage and candidate gene studies have identified several
breast cancer susceptibility genes, but the overall
contribution of coding variation to breast cancer is
unclear. To evaluate the role of rare coding variants more
comprehensively, we performed a meta-analysis across three
large whole-exome sequencing datasets, containing 26,368
female cases and 217,673 female controls. Burden tests were
performed for protein-truncating and rare missense variants
in 15,616 and 18,601 genes, respectively. Associations
between protein-truncating variants and breast cancer were
identified for the following six genes at exome-wide
significance (P < 2.5 × 10-6): the five known
susceptibility genes ATM, BRCA1, BRCA2, CHEK2 and PALB2,
together with MAP3K1. Associations were also observed for
LZTR1, ATR and BARD1 with P < 1 × 10-4. Associations
between predicted deleterious rare missense or
protein-truncating variants and breast cancer were
additionally identified for CDKN2A at exome-wide
significance. The overall contribution of coding variants in
genes beyond the previously known genes is estimated to be
small.},
cin = {C020},
ddc = {570},
cid = {I:(DE-He78)C020-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:37592023},
doi = {10.1038/s41588-023-01466-z},
url = {https://inrepo02.dkfz.de/record/282340},
}